SOP for TMF access logs – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Wed, 03 Sep 2025 20:47:27 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for Access Control and User Authorization (Paper/Electronic) https://www.clinicalstudies.in/sop-for-access-control-and-user-authorization-paper-electronic/ Wed, 03 Sep 2025 20:47:27 +0000 ]]> https://www.clinicalstudies.in/?p=6998 Read More “SOP for Access Control and User Authorization (Paper/Electronic)” »

]]>
SOP for Access Control and User Authorization (Paper/Electronic)

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-Access-Control-and-User-Authorization”
},
“headline”: “SOP for Access Control and User Authorization (Paper/Electronic) in Clinical Trials”,
“description”: “This SOP defines procedures for access control and user authorization in both paper and electronic systems in clinical trials, ensuring compliance with ICH GCP, FDA, EMA, CDSCO, and WHO guidelines for data security and integrity.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Access Control and User Authorization (Paper/Electronic)

Department Clinical Research
SOP No. CR/SYS/057/2025
Supersedes NA
Page No. 1 of 22
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to establish secure processes for managing access control and user authorization in both paper-based and electronic clinical trial systems. Proper access control ensures data confidentiality, integrity, and accountability, protecting trial data from unauthorized access or alteration.

Scope

This SOP applies to all clinical trial stakeholders including investigators, study coordinators, CRAs, data managers, CROs, and sponsors. It covers paper record access, electronic system authorization, password management, periodic access reviews, and access revocation.

Responsibilities

  • Principal Investigator (PI): Authorizes site staff access to trial-related records and systems.
  • Study Coordinator: Manages site-level access logs and ensures compliance with access policies.
  • Data Manager: Manages user accounts in electronic data capture (EDC) and clinical databases.
  • Sponsor/CRO: Ensures secure access control policies are implemented and periodically reviewed.
  • QA Officer: Audits access logs and verifies compliance with access control SOPs.

Accountability

The PI is accountable for authorizing access at site level, while the sponsor is accountable for global oversight and system-level access compliance.

Procedure

1. Paper Record Access Control
Store trial documents (ISF, CRFs, source documents) in locked cabinets with restricted key access.
Maintain a Paper Access Log (Annexure-1) recording date, name, purpose, and authorization of access.

2. Electronic System Access
Access to EDC, CDMS, and safety databases must be role-based.
Provide unique user IDs and enforce strong password policies.
Maintain audit trails for all login, modification, and logout activities.

3. User Authorization
PI or sponsor must approve user account creation.
Document authorization in User Authorization Log (Annexure-2).
Assign roles based on job responsibilities (e.g., data entry, monitor, PI, sponsor).

4. Access Reviews
Conduct quarterly access reviews to ensure active users are current trial staff.
Immediately revoke access for staff leaving the study.

5. Access Revocation
Inactive or unauthorized accounts must be disabled immediately.
Record revocation details in Access Revocation Log (Annexure-3).

6. Archiving
Archive access logs and authorization records in ISF/TMF.
Retain access control documentation for a minimum of 15 years.

Abbreviations

  • SOP: Standard Operating Procedure
  • PI: Principal Investigator
  • CRA: Clinical Research Associate
  • CRO: Clinical Research Organization
  • QA: Quality Assurance
  • ISF: Investigator Site File
  • TMF: Trial Master File
  • EDC: Electronic Data Capture
  • CDMS: Clinical Data Management System

Documents

  1. Paper Access Log (Annexure-1)
  2. User Authorization Log (Annexure-2)
  3. Access Revocation Log (Annexure-3)

References

Version: 1.0

Approval Section

Prepared By Rajesh Kumar, Clinical Data Manager
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Principal Investigator

Annexures

Annexure-1: Paper Access Log

Date Name Role Document Accessed Authorized By
12/09/2025 Ravi Kumar CRA ISF Progress Notes PI

Annexure-2: User Authorization Log

Date User ID Name Role Authorized By
13/09/2025 CT-USER-221 Sunita Reddy QA Officer Sponsor

Annexure-3: Access Revocation Log

Date User ID Name Reason for Revocation Revoked By
15/09/2025 CT-USER-198 Arun Mehta Staff resignation Data Manager

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head, Clinical Research

For more SOPs visit: Pharma SOP

]]>
Documentation of TMF Retrieval and Access Logs https://www.clinicalstudies.in/documentation-of-tmf-retrieval-and-access-logs/ Tue, 05 Aug 2025 18:34:58 +0000 https://www.clinicalstudies.in/?p=4319 Read More “Documentation of TMF Retrieval and Access Logs” »

]]>
Documentation of TMF Retrieval and Access Logs

Compliant TMF Retrieval and Access Log Documentation Explained

Why TMF Access Logs Are Critical for Regulatory Compliance

Trial Master File (TMF) access logs provide a regulatory audit trail of who accessed archived documents, when, and for what purpose. Whether for physical or electronic TMFs, access logs are a cornerstone of data integrity and Good Clinical Practice (GCP) compliance.

As per FDA and EMA guidance, TMF documents must be “readily retrievable” while maintaining their confidentiality and integrity. This means every retrieval event must be authorized, recorded, and reviewed.

In this guide, we’ll explain how to design access logs and retrieval documentation workflows to ensure inspection-readiness and safeguard archived TMF records.

Who Accesses the TMF—and Why It Must Be Logged

Typical personnel who may retrieve TMF documents include:

  • Clinical Research Associates (CRAs)
  • Regulatory Affairs personnel
  • Auditors and QA teams
  • Sponsors or inspectors (upon formal request)
  • TMF Custodians or Archivists

Each retrieval must be justified and documented in a standardized format. Failure to log retrievals can lead to regulatory observations, especially if document integrity or unauthorized access is questioned.

Components of a TMF Retrieval Log

Whether maintained manually or electronically, a compliant TMF access log should include:

  • Date and time of access
  • Name and role of the person accessing
  • Document(s) retrieved (with file ID or box number)
  • Reason for access (e.g., audit, inspection, revalidation)
  • Method of retrieval (onsite, scanned, couriered)
  • Authorized approver’s signature or digital approval

A sample entry might look like:

2024-05-10 | Smith, QA Lead | ICF_V2_1032.pdf | CAPA Review | Electronic (VPN) | Approved by QA Manager
      

For editable templates of retrieval logs and access request forms, visit PharmaSOP.in.

Electronic TMF (eTMF) Access Tracking and Audit Trails

In an electronic TMF (eTMF) environment, user access is automatically logged by the system. These audit trails must be configured to capture detailed metadata about every interaction with TMF documents.

System-Generated Audit Trails Should Capture:

  • Login/logout timestamps
  • Document view, download, and edit actions
  • User ID and assigned role
  • IP address or access location (if applicable)
  • Reason or purpose (when configured)

Regulatory authorities such as the ICH and CDSCO expect these audit trails to be uneditable, permanently retained, and reviewed periodically.

Managing Retrieval Frequency and Access Reviews

Repeated access to the same TMF record—especially from external parties—should trigger an internal review. This ensures that TMF documents aren’t being misused, improperly distributed, or accessed without proper oversight.

Recommended Controls:

  • Quarterly reviews of TMF access logs by QA
  • Flagging users with unusually high access activity
  • Role-based access limits with justification for overrides
  • Escalation triggers when access exceeds thresholds

These proactive reviews form part of the TMF’s Quality Management System (QMS) and support continual improvement under GCP.

Retention of Access Logs and Retrieval Documentation

Access logs themselves must be retained for the same duration as the TMF—often 25 years depending on jurisdiction. Logs must be archived securely and remain auditable throughout the retention period.

  • Store physical access logs in the Quality Archive
  • Export and digitally sign eTMF audit trails annually
  • Link retrieval requests to associated CAPAs, audits, or investigations
  • Ensure all logs are backed up and validated for long-term readability

Case Study: TMF Access Documentation in an EMA Inspection

During a recent EMA inspection, a sponsor was asked to provide access logs for a protocol amendment viewed six months earlier by a CRO. The sponsor produced an access request form and eTMF audit trail showing date, time, and download path. The inspector praised the traceability, noting the sponsor’s exemplary retrieval practices.

In contrast, a separate site failed to log access to a subject signature page, resulting in a major observation and subsequent re-training of all TMF custodians.

Conclusion: Make Retrieval Logs a Compliance Tool, Not a Burden

Properly documented TMF retrieval and access logs not only meet regulatory expectations—they protect the integrity of your study data. Whether paper-based or digital, every TMF access event should be justified, authorized, and recorded.

Sponsors and CROs that implement robust retrieval SOPs, automated logging tools, and periodic reviews are more likely to withstand inspections and prove their commitment to quality and transparency.

For log templates, SOP checklists, and eTMF audit configuration guides, visit PharmaValidation.in.

]]>